Drug addiction

FILE - In this Tuesday, June 19, 2018 file photo Cheryl Juaire walks past a photo of her son, Corey Merrill, at her home in Marlborough, Mass. Victims of opioid addiction weren’t in the room when big decisions were hammered out in OxyContin maker Purdue Pharma’s proposal to settle claims over its role in the U.S. opioid crisis. Cheryl Juaire lost her 23-year-old son to a heroin overdose after he became addicted to prescription painkillers. (AP Photo/Steven Senne, File)
October 06, 2019 - 3:50 pm
Victims of opioid addiction weren't in the room when OxyContin maker Purdue Pharma persuaded half the state attorneys general to settle claims over the company's role in the nationwide overdose epidemic. Now that Purdue is in federal bankruptcy court, four people whose lives were touched by...
Read More
CORRECTS STATE TO OHIO NOT PENNSYLVANIA - Narcotics detective Ben Hill, with the Barberton Police Department, shows two bags of medications that are are stored in their headquarters and slated for destruction, Wednesday, Sept. 11, 2019, in Barberton, Ohio. Attorneys representing some 2,000 local governments said Wednesday they have agreed to a tentative settlement with OxyContin maker Purdue Pharma over the toll of the nation's opioid crisis. (AP Photo/Keith Srakocic)
September 11, 2019 - 7:51 pm
HARTFORD, Conn. (AP) — A tentative settlement announced Wednesday over the role Purdue Pharma played in the nation's opioid addiction crisis falls short of the far-reaching national settlement the OxyContin maker had been seeking for months, with litigation sure to continue against the company and...
Read More
September 05, 2019 - 2:44 pm
ROME (AP) — Italian authorities on Thursday suspended a doctor and three pharmacists in an investigation of the suspected fraudulent prescription of oxycodone, a potentially addictive painkiller. In allegations that appear to have similarities to the U.S. opioid addiction epidemic, a physician in...
Read More
FILE - In this Friday, Aug. 17, 2018, file photo, Christine Gagnon of Southington, Conn., protests with other family and friends who have lost loved ones to OxyContin and opioid overdoses at Purdue Pharma LLP headquarters in Stamford, Conn. Gagnon lost her son Michael 13 months earlier. OxyContin maker Purdue Pharma is expected to file for bankruptcy after settlement talks over the nation’s deadly overdose crisis hit an impasse, attorneys general involved in the talks said Saturday, Sept. 7, 2019, in a message to their counterparts across the country. (AP Photo/Jessica Hill, File)
August 30, 2019 - 10:50 pm
HARTFORD, Conn. (AP) — An offer from OxyContin maker Purdue Pharma and the Sackler family to settle some 2,000 lawsuits over their contribution to the national opioid crisis is receiving growing pushback from state and local officials who say the proposed deal doesn't include enough money or...
Read More
Judge Thad Balkman announces his decision in the Opioid Lawsuit In Norman, Okla., Monday, Aug. 26, 2019. Balkman found Johnson & Johnson and its subsidiaries helped fuel the state's opioid drug crisis and ordered the consumer products giant to pay $572 million to help abate the problem in the coming years. (AP Photo/Sue Ogrocki, Pool)
August 27, 2019 - 7:01 pm
OKLAHOMA CITY (AP) — Oklahoma's legal fight against the opioid industry has racked up settlements and judgments of nearly $1 billion, but as the numbers keep rising, so do concerns over how that money will be spent. Experts say the $572 million judgment issued Monday against consumer products giant...
Read More
Protesters, including Carol Lorento, center, gather outside a courthouse on Friday, Aug. 2, 2019, in Boston, where a judge was to hear arguments in Massachusetts' lawsuit against Purdue Pharma over its role in the national drug epidemic. Organizers said they wanted to continue to put pressure on the Connecticut pharmaceutical company and the Sackler family that owns it. (AP Photo/Charles Krupa)
August 02, 2019 - 1:45 pm
BOSTON (AP) — They came bearing oversized images of the sons and daughters they lost to drug overdoses and signs demanding justice from the pharmaceutical company they hold most responsible. The parents and their supporters rallied outside a Boston courthouse Friday as a judge heard arguments in...
Read More
FILE - In this Aug. 17, 2018 file photo, Christine Gagnon, of Southington, Conn., holds a sign during a protest with others who have lost loved ones to OxyContin and opioid overdoses, outside the Purdue Pharma headquarters in Stamford, Conn. Gagnon lost her son Michael 13 months earlier. Nearly ten years ago, the blockbuster painkiller OxyContin was reformulated to discourage abuse by snorting and injecting, but it's unclear whether the harder-to-abuse format has decreased cases of addiction, overdose and death. (AP Photo/Jessica Hill, File)
July 22, 2019 - 12:32 pm
WASHINGTON (AP) — Dr. Raeford Brown was uniquely positioned to help the U.S. government answer a critical question: Is a new version of the painkiller OxyContin helping fight the national opioid epidemic? An expert in pain treatment at the University of Kentucky, Brown led a panel of outside...
Read More
FILE - In this Aug. 17, 2018 file photo, Christine Gagnon, of Southington, Conn., holds a sign during a protest with others who have lost loved ones to OxyContin and opioid overdoses, outside the Purdue Pharma headquarters in Stamford, Conn. Gagnon lost her son Michael 13 months earlier. Nearly ten years ago, the blockbuster painkiller OxyContin was reformulated to discourage abuse by snorting and injecting, but it's unclear whether the harder-to-abuse format has decreased cases of addiction, overdose and death. (AP Photo/Jessica Hill, File)
July 22, 2019 - 10:37 am
WASHINGTON (AP) — Nearly a decade ago, the maker of OxyContin responded to a growing wave of opioid abuse by making the painkiller harder to snort and inject. But has that reformulation translated into fewer drug overdoses and deaths? It's a question that experts like Dr. Raeford Brown of the...
Read More
July 11, 2019 - 11:58 am
LONDON (AP) — Consumer products company Reckitt Benckiser says it will pay $1.4 billion to resolve U.S. investigations into the marketing of an anti-addiction drug by a subsidiary. The company said Thursday it reached agreements with the U.S. Department of Justice and the Federal Trade Commission...
Read More
Dr. Nora Volkow, director of the National Institute on Drug Abuse, works in the MRI lab at the National Institutes of Health’s research hospital in Bethesda, Md., on Thursday May 16, 2019. Volkow is studying how anti-addiction medicines work inside the brains of people undergoing treatment for opioid abuse. In the background are NIH neuroimaging specialists Dana Feldman and Danielle Kroll. (AP Photo/Carolyn Kaster)
July 09, 2019 - 11:49 am
BETHESDA, Md. (AP) — Lying inside a scanner, the patient watched as pictures appeared one by one: A bicycle. A cupcake. Heroin. Outside, researchers tracked her brain's reactions to the surprise sight of the drug she'd fought to kick. Government scientists are starting to peek into the brains of...
Read More

Pages